Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

64
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
64
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

2.0K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

4.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Principles of Drug Action01:24

Principles of Drug Action

9.5K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.5K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canonical autophagy remains inactive in induced pluripotent stem cells and neuronal progenitor cells following DNA damage induced by BPDE or etoposide.

Scientific reports·2026
Same author

Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1.

Cell death & disease·2026
Same author

Correction: Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid.

Frontiers in molecular biosciences·2026
Same author

Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Cell death & disease·2025
Same author

SIRT4 positively regulates autophagy via ULK1, but independently of HDAC6 and OPA1.

FEBS open bio·2025
Same author

Spinulactones A-F: Bioactive Drimane-Type Sesquiterpenes from the Endophytic <i>Penicillium spinulosum</i> 9-1.

Journal of natural products·2025

Related Experiment Video

Updated: Apr 7, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

801

Phomoxanthone A--From Mangrove Forests to Anticancer Therapy.

Marian Frank, Hendrik Niemann, Philip Böhler

  • 1Department of Pharmaceutical Biology and Biotechnology, Faculty of Pharmacy, Heinrich- Heine University, 40225 Duesseldorf, Germany. proksch@uni-duesseldorf.de.

Current Medicinal Chemistry
|July 17, 2015
PubMed
Summary

Phomoxanthone A (PXA), a compound from mangrove fungi, shows potent anticancer activity by inducing apoptosis and activating immune cells. This natural product offers a promising lead for overcoming cancer drug resistance.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 7, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

801
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Immunology

Background:

  • Mangrove endophytes are a rich source of novel bioactive compounds.
  • Drug resistance in cancer necessitates the discovery of new therapeutic leads.
  • Phomoxanthone A (PXA) is a potent anti-tumor compound isolated from Phomopsis longicolla.

Purpose of the Study:

  • To highlight the anti-tumor potential of phomoxanthone A (PXA).
  • To investigate the mechanism of action of PXA against cancer cells.
  • To explore the immunomodulatory effects of PXA.

Main Methods:

  • In vitro testing of PXA against various cancer cell lines, including cisplatin-resistant ones.
  • Assessment of PXA's cytotoxicity against peripheral blood mononuclear cells (PBMC).
  • Analysis of PXA's mechanism of action via caspase 3 activation and apoptosis induction.
  • Evaluation of PXA's effect on immune cell activation (T-lymphocytes, NK cells, macrophages).
  • Structure-activity relationship studies of PXA derivatives.

Main Results:

  • PXA exhibited strong anti-tumor activity with submicromolar IC50 values against solid and blood cancer cell lines.
  • PXA showed significantly lower activity against healthy donor PBMC.
  • The anti-tumor effect of PXA is mediated by caspase 3-dependent apoptosis.
  • PXA demonstrated immune cell activation, potentially aiding cancer chemotherapy.
  • Specific structural features of PXA, including the biaryl linkage and acetyl groups, are crucial for its activity.

Conclusions:

  • Phomoxanthone A is a potent anti-cancer agent derived from mangrove fungi.
  • PXA's dual action of inducing apoptosis and activating immune cells makes it a promising candidate for cancer therapy.
  • Structure-activity relationship studies provide insights for developing more effective PXA analogs.